Clinical Trial Update: Low Dose Ketamine VR Analgesia During Burn Care Procedure [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating low-dose ketamine delivered with virtual reality analgesia during burn care procedures has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burn Injuries

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: National Institute of General Medical Sciences (NIGMS) | Conditions: Burn | Phase 2 | Status: COMPLETED